Centogene N.V.
NASDAQ:CNTG
0.33 (USD) • At close November 14, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Centogene N.V. |
Symbool | CNTG |
Munteenheid | USD |
Prijs | 0.325 |
Beurswaarde | 9,425,033 |
Dividendpercentage | 0% |
52-weken bereik | 0.325 - 0.325 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Kim Stratton |
Website | https://www.centogene.com |
An error occurred while fetching data.
Over Centogene N.V.
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)